Menu Search
Equities

BIO-Key International Inc

BJO0:BER

BIO-Key International Inc

Actions
  • Price (EUR)2.59
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-78.98%
  • Beta--
Data delayed at least 15 minutes, as of Dec 20 2023 20:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BIO-key International, Inc. is an identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers. The Company’s products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, AuthControl Sentry, AuthControl Enterprise, AuthControl MSP, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to provide a complete solution for its customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. Its WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. It also offers biometric software integration APIs.

  • Revenue in USD (TTM)6.85m
  • Net income in USD-8.74m
  • Incorporated2004
  • Employees43.00
  • Location
    BIO-Key International Inc101 Crawfords Corner Rd, Suite 4116HOLMDEL 07733United StatesUSA
  • Phone+1 (732) 359-1100
  • Fax+1 (651) 687-0515
  • Websitehttp://www.bio-key.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.